Post by Rashad Ismayilov

I am pleased to share our recently published article in Immunotherapy: Time-dependent Prognostic Impact of Distant Metastatic Sites in Small Cell Lung Cancer: A Comparative Analysis of Pre- and Post-Immunotherapy Eras Using data from 43,279 patients with metastatic SCLC, we evaluated how the prognostic significance of metastatic sites has evolved in the immunotherapy era. Liver metastasis remained the strongest adverse prognostic factor, while the negative impact of brain metastasis appeared substantially attenuated in the modern treatment era. Many thanks to my co-authors and collaborators for their valuable contributions. 🔗 Full article: https://lnkd.in/euJsinUc Taylor & Francis Group